Cargando…
The MSBase pregnancy, neonatal outcomes, and women’s health registry
BACKGROUND: Family planning and pregnancy decisions are key considerations in the management of women with multiple sclerosis (MS), who are typically diagnosed between the ages of 20–40 years. Despite a strong evidence base that pregnancy is not harmful for women with MS, many knowledge gaps remain....
Autores principales: | Jokubaitis, Vilija G., Skibina, Olga, Alroughani, Raed, Altintas, Ayse, Butzkueven, Helmut, Eichau, Sara, Fragoso, Yara, Hellwig, Kerstin, Hughes, Stella E., Rath, Louise, van der Walt, Anneke, Gray, Orla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047930/ https://www.ncbi.nlm.nih.gov/pubmed/33912245 http://dx.doi.org/10.1177/17562864211009104 |
Ejemplares similares
-
Comparative effectiveness of cladribine tablets versus other oral
disease-modifying treatments for multiple sclerosis: Results from MSBase
registry
por: Spelman, Tim, et al.
Publicado: (2022) -
Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudy
por: Lizak, Nathaniel, et al.
Publicado: (2020) -
The Australian Multiple Sclerosis (MS) Immunotherapy Study: A Prospective, Multicentre Study of Drug Utilisation Using the MSBase Platform
por: Jokubaitis, Vilija G., et al.
Publicado: (2013) -
High rates of JCV seroconversion in a large international cohort of natalizumab-treated patients
por: Dwyer, Christopher M., et al.
Publicado: (2021) -
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry
por: Butzkueven, Helmut, et al.
Publicado: (2021)